ClinicalTrials.gov
ClinicalTrials.gov Menu

S9925: Collecting and Storing Samples From Patients With Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00920010
Recruitment Status : Completed
First Posted : June 12, 2009
Last Update Posted : February 6, 2015
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group

Brief Summary:

RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.


Condition or disease Intervention/treatment
Lung Cancer Other: biologic sample preservation procedure

Detailed Description:

OBJECTIVES:

  • Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
  • Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
  • Test new hypotheses with the specimens in the repository.

OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.

PROJECTED ACCRUAL: Not specified


Study Type : Observational
Actual Enrollment : 2264 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lung Cancer Specimen Repository Protocol, Ancillary
Study Start Date : September 2000
Actual Primary Completion Date : January 2013
Actual Study Completion Date : January 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer
U.S. FDA Resources




Primary Outcome Measures :
  1. Establishment of a central lung cancer specimen repository to serve as a resource for current and future scientific studies [ Time Frame: From date of study activation to consolidation of specimen banks ]
  2. Correlation of clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository [ Time Frame: From date of study activation to consolidation of specimen banks ]
  3. Test of new hypotheses with the specimens in the repository [ Time Frame: From date of study activation to consolidation of specimen banks ]

Biospecimen Retention:   Samples With DNA
Fixed tissue in paraffin blocks or slides, slides of buccal brushings, fresh frozen tissue peripheral blood, serum, plasma, white blood cells, and sputum.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Lung cancer patients registered to SWOG lung protocols.
Criteria

DISEASE CHARACTERISTICS:

  • Enrolled on one of the following Southwest Oncology Group protocols:

    • SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124

PATIENT CHARACTERISTICS: Not specified

PRIOR CONCURRENT THERAPY: Not specified


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00920010


  Show 431 Study Locations
Sponsors and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Investigators
Study Chair: Wilbur A. Franklin, MD University of Colorado, Denver

Responsible Party: Southwest Oncology Group
ClinicalTrials.gov Identifier: NCT00920010     History of Changes
Other Study ID Numbers: CDR0000078624
S9925 ( Other Identifier: SWOG )
U10CA032102 ( U.S. NIH Grant/Contract )
First Posted: June 12, 2009    Key Record Dates
Last Update Posted: February 6, 2015
Last Verified: February 2015

Keywords provided by Southwest Oncology Group:
non-small cell lung cancer
small cell lung cancer

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases